Healthcare · Oslo Børs. Last price 8.20 NOK (-0.49% on the day). Raven's AI 12-month target for Lytix Biopharma (12.00 NOK) is 20.0% below the analyst median (15.00 NOK, 2 analysts). Updated 2026-10-09.
Paper-trade Lytix Biopharma free with 100 000 fake NOK and compete with other players on Raven Trading Game.
Raven's AI sets a 12-month target of 12.00 NOK (+45.63% from 8.24 when it was set on 2026-10-09). Conviction: medium.
Catalysts: Clinical trial readout; Partner validation deal; Regulatory approval milestone
Risks: Clinical trial delay/failure; Fundraising dilution; Competitor advance
Home · All Oslo Børs stocks · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot
More Healthcare stocks: ABS Arctic Bioscience · ABTEC Aqua Bio Technology · AZT ArcticZymes Technologies · CODE CodeLab Capital · CONTX ContextVision · CRNA Circio Holding ASA · EXTX EXACT Therapeutics · INDCT Induct